Genome sequencing has been widely deployed to study the evolution of SARS-CoV-2 with
more than 90,000 genome sequences uploaded to the GISAID database. We published a …

Background The magnitude and durability of immune responses to coronavirus disease
2019 (COVID-19) mRNA vaccines remain incompletely characterized in the elderly. Methods …

Humoral responses to COVID-19 vaccines in people living with HIV (PLWH) remain
incompletely characterized. We measured circulating antibodies against the SARS-CoV-2 spike …

… Hope R Lapointe , Hope R Lapointe … We thank the phlebotomists and laboratory staff at St
Paul's Hospital, the BC Centre for Excellence in HIV/AIDS, the Hope to Health Research and …

Background: Longer-term humoral responses to two-dose COVID-19 vaccines remain
incompletely characterized in people living with HIV (PLWH), as do initial responses to a third …

Efforts to cure HIV have focused on reactivating latent proviruses to enable elimination by
CD8 + cytotoxic T-cells. Clinical studies of latency reversing agents (LRA) in antiretroviral …

In a multi-center longitudinal observational cohort of people with HIV in Canada, COVID-19
vaccination humoral immunogenicity was assessed in 294 individuals with and 267 without …

Background Longer-term humoral responses to 2-dose coronavirus disease 2019 (COVID-19)
vaccines remain incompletely characterized in people living with human …

Background: Limited data exist regarding longer term antibody responses following three-dose
coronavirus disease 2019 (COVID-19) vaccination, and the impact of a first SARS-CoV-2 …

Background. Several Canadian provinces are extending the interval between COVID-19
vaccine doses to increase population vaccine coverage more rapidly. However, …